Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist DiscontinuationJacqueline Maya, Camille E. Powe, Deepti Pant et al.|JAMA|2025Cited by 51
1214-P: Prepregnancy Use of Glucagon-Like Peptide 1 Receptor Agonists and Gestational Weight Gain in Type 2 DiabetesJacqueline Maya, CAMILLE E. POWE, Kaitlyn James et al.|Diabetes|2024Cited by 7
The Risk of Hypertensive Disorders of Pregnancy in Inflammatory Bowel DiseaseLindsay Clarke, Camille E. Powe, Sarah Hsu et al.|The American Journal of Gastroenterology|2025Cited by 2
S1398 Risk of Hypertensive Disorders of Pregnancy in Inflammatory Bowel DiseaseLindsay Clarke, Camille E. Powe, Sarah Hsu et al.|The American Journal of Gastroenterology|2024Cited by 1
Gestational Glucose Intolerance and the Risk of Hypertensive Disorders of PregnancyJacqueline Maya, Camille E. Powe, Kaitlyn E. James et al.|Journal of the American Heart Association|2026Cited by 1